Statistics for Patients with Muscle-Invasive Bladder Cancer with Nonluminal Subtype Derive Greatest Benefit from Platinum Based Neoadjuvant Chemotherapy
Total visits
views | |
---|---|
Patients with Muscle-Invasive Bladder Cancer with Nonluminal Subtype Derive Greatest Benefit from Platinum Based Neoadjuvant Chemotherapy | 60 |
Total visits per month
views | |
---|---|
August 2024 | 0 |
September 2024 | 0 |
October 2024 | 0 |
November 2024 | 0 |
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
File Visits
views | |
---|---|
Lotan2022Patients-CCBYNCND.pdf | 50 |
java.util.UUID:e7354877-9552-4232-a986-213bc5353921 | 11 |
java.util.UUID:e3cd4ee3-2d48-45cf-91a8-a7e819c3c049 | 3 |
java.util.UUID:577b062d-64a4-4214-b2d6-1cf28a9f0c9e | 2 |
Top country views
views | |
---|---|
United States | 53 |
China | 1 |
Netherlands | 1 |
Top city views
views | |
---|---|
Wilmington | 43 |
Ann Arbor | 2 |
Lake Mary | 2 |
Apeldoorn | 1 |
Ashburn | 1 |
Chengdu | 1 |
Greenwood | 1 |
Mount Laurel | 1 |
White Plains | 1 |
Zionsville | 1 |